To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program.

Summary

This bill limits cost-sharing for covered drugs under the Medicare prescription drug benefit and Medicare Advantage. Specifically, for costs above the deductible but below the annual out-of-pocket threshold, the bill limits cost-sharing to the average net price of the drug (i.e., the average amount paid less any rebates) or the cash price (i.e., the price charged to an individual without insurance), whichever is lower.  The Government Accountability Office must report on the bill's implementation.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 25 July 2023

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 25 July 2023

   Introduced

   Introduced in House

   Source: IntroReferral

3. 25 July 2023

   Introduced

   Introduced in House

   Source: IntroReferral

4. 28 July 2023

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 15 November 2023

   Committee

   Forwarded by Subcommittee to Full Committee by Voice Vote.

   Source: Committee

6. 15 November 2023

   Committee

   Subcommittee Consideration and Mark-up Session Held

   Source: Committee

7. 5 December 2023

   Committee

   Committee Consideration and Mark-up Session Held

   Source: Committee

8. 6 December 2023

   Committee

   Committee Consideration and Mark-up Session Held

   Source: Committee

9. 6 December 2023

   Vote

   Ordered to be Reported (Amended) by the Yeas and Nays: 45 - 0.

   Source: Committee

10. 17 December 2024

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 25 July 2023 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 25 July 2023

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 25 July 2023

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 25 July 2023

  Open at official source

Sponsors

• Rep. Malliotakis, Nicole [R-NY-11] · R · Sponsor
• Brad Wenstrup · R · Sponsor
• · hswm00 · Standing
• · hsif00 · Standing

Related records

• related to → Health Care Price Transparency Act of 2023